RA and HIV PrEP successes, to flops in DMD and Alzheimer’s, Clinical Trials Arena rounds up the biggest trial read outs of ...

A phase 3 clinical trial, explorer8, has demonstrated the efficacy and safety of concizumab, a monoclonal antibody in ...

Purpose: The implications of recent studies for guidelines that pertain to stress ulcer prophylaxis in the postoperative period are discussed. Summary: The therapeutic guidelines on stress ulcer ...

Background The use of quinolone prophylaxis in high-risk neutropenic patients is considered standard of care but the development of resistance is a concern. Previous studies have focused mainly on ...

Historically, sickle cell anaemia has been widely neglected within its global epicentre of sub-Saharan Africa. More than ...

The Philippines is witnessing a rapid rise in HIV infections, recording a 543% rise in cases between 2010 and 2023. One in ...

Plainsboro: Novo Nordisk has announced that the U.S. Food and Drug Administration (FDA) has approved Alhemo (concizumab-mtci) ...

A national survey of Canadian hematologists reveals gaps and variability in supportive care strategies for older adults with ...

Novo Nordisk (NVO) wins U.S. FDA nod for its Alhemo injection as a once-daily prophylaxis for bleeding prevention in patients ...

Undeterred by last year’s rejection and the recent approval of a close rival from Pfizer, Novo Nordisk has pushed its ...

Implementation of a time-out checklist in the trauma bay may encourage compliance with guideline recommendations for ...

Altuviiio (efanesoctocog alfa) may work better than other treatments as a hemophilia A factor replacement therapy, a study ...